Sell RIM!: Against ...
Health Care: Drugs
Catalyst Pharmaceutical Partners Inc. (CPRX: NASDAQ)
$0.57 0.00 | 0.04%
06/04/12 - 03:54 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 6.03M | 5.48M | 7.78M | 11.77M |
| Receivables | 0.00 | 134.02K | 0.00 | 12.00K |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 6.23M | 5.78M | 7.89M | 11.92M |
| Property, Plant & Equipment, Gross | 71.26K | 156.73K | 153.86K | 151.00K |
| Accumulated Depreciation & Depletion | 59.07K | 111.15K | 85.41K | 55.00K |
| Property, Plant & Equipment, Net | 12.19K | 45.57K | 68.45K | 96.00K |
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 8.89K | 10.51K | 10.51K | 21.00K |
| Total Non-Current Assets | 21.07K | 56.08K | 78.96K | 117.00K |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 6.25M | 5.83M | 7.97M | 12.03M |
| Accounts Payable | 263.93K | 105.93K | 249.64K | 333.00K |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 833.80K | 298.96K | 294.15K | 1.43M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 1.65M | 14.75K | 54.37K | 43.00K |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 1.65M | 14.75K | 54.37K | 43.00K |
| Total Liabilities | 2.49M | 313.71K | 348.52K | 1.47M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 3.76M | 5.52M | 7.62M | 10.56M |
| Common Par | 24.70K | 19.40K | 18.04K | 14.00K |
| Additional Paid In Capital | 41.84M | 37.21M | 35.31M | 31.01M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -38.10M | -31.71M | -27.71M | -20.46M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Capitalization | 3.76M | 5.52M | 7.62M | 10.56M |
| Total Equity | 3.76M | 5.52M | 7.62M | 10.56M |
| Total Liabilities & Stock Equity | 6.25M | 5.83M | 7.97M | 12.03M |
| Total Common Shares Outstanding | 24.70M | 19.39M | 18.04M | 14.16M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 21.73M | 18.58M | 15.07M | 13.01M |
| Diluted Weighted Shares Outstanding | 21.73M | 18.58M | 15.07M | 13.01M |
| Number of Employees | 6 | 6 | 6 | 7 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with CPRX
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- UserSUPRATRADE EX-1006090013 DE...
- Userzhuangsn
- UserBRR Portfolio 1
- Userjaxplace Portfolio 1
- Usersovnek Portfolio 1
- UserDj Paul
- Userlouiis Portfolio 1
- Usercjthurman Portfolio 1
- Userajsny Portfolio 1
Latest CPRX Headlines from TheStreet
- 5 Stocks Setting Up to Break Out 12.20.11 | 01:12 pm
- Catalyst Announces Commencement Of CPP-109 Investigator-Sponsored Study In Cocaine And Alcohol Co-Dependent Patients 03.29.11 | 08:03 am
- Catalyst Pharmaceutical Partners To Present At The ROTH 23rd Annual OC Growth Stock Conference 03.09.11 | 11:03 am
- Catalyst Pharmaceutical Partners, Inc. Announces Public Offering Of Common Shares 03.08.11 | 09:03 am
- Catalyst Pharmaceutical Partners Promotes Steven R. Miller, Ph.D. To Chief Operating Officer 01.25.11 | 08:01 am
- Catalyst Pharmaceutical Partners To Present At The Biotech Showcase(TM) 2011 Conference 01.04.11 | 08:01 am
- Canadian Intellectual Property Office Grants Broad Patent For The Use Of Vigabatrin/CPP-109 For The Prevention Of Addiction In Pain Management 12.09.10 | 08:12 am
- Catalyst Pharmaceutical Partners Initiates A Registration-Directed U.S. Phase II(b) Clinical Trial In Collaboration With The National Institute On Drug Abuse And Veteran's Administration Cooperative Studies Program 11.18.10 | 08:11 am
- Catalyst Pharmaceutical Partners Announces Third Quarter 2010 Financial And Operational Results 11.16.10 | 08:11 am
- Dr. Richard B. Silverman Joins Catalyst Pharmaceutical Partners' Scientific Advisory Board 11.15.10 | 08:11 am
Press Releases for CPRX
- Vigabatrin/CPP-109 Data To Be Presented At College On Problems Of Drug Dependence Annual Meeting - PR Newswire 06.09.10 | 08:06 am
- Catalyst Pharmaceutical Partners To Present At The MoneyShow Conference - PR Newswire 05.07.10 | 08:05 am
- Catalyst Pharmaceutical Partners Regains Compliance With NASDAQ Minimum Bid Price Rule - PR Newswire 04.26.10 | 11:04 am
- Catalyst Pharmaceutical Partners Signs Definitive Agreement With The National Institute On Drug Abuse To Conduct U.S. Phase II(B) Clinical Trial For Cocaine Addiction - PR Newswire 04.13.10 | 10:04 am
- CPP-109 Clinical Trial Data To Be Presented At The American Society Of Addiction Medicine Annual Medical-Scientific Conference - PR Newswire 04.09.10 | 08:04 am
- Catalyst Pharmaceutical Partners Reports Fourth Quarter And Year-End 2009 Financial Results - PR Newswire 04.01.10 | 08:04 am
- Catalyst Pharmaceutical Partners To Present At The BioNetwork East 2010 Conference - PR Newswire 03.10.10 | 08:03 am
- Catalyst Pharmaceutical Partners To Present Today At 2010 Epilepsy Pipeline Update Conference - PR Newswire 02.25.10 | 08:02 am
- Catalyst Pharmaceutical Partners And The National Institute On Drug Abuse Plan To Initiate U.S. Phase II(b) Clinical Trial For Cocaine Addiction - PR Newswire 02.23.10 | 08:02 am
- Catalyst Pharmaceutical Partners Selected To Present At Epilepsy Conference Highlighting New And Promising Therapies - PR Newswire 02.17.10 | 08:02 am
Partner Headlines for CPRX
- Weekly CFO Buys Highlight: EMC, DVOX, NANX, CPRX, CCRN - GuruFocus 06.04.12 | 01:06 pm
- 7 Stocks Under $6 Poised To Double In 2012 - Seeking Alpha 11.24.11 | 06:11 am
- 6 Biotechs That Could See Huge Gains (Like Inhibitex) - Seeking Alpha 11.11.11 | 09:11 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 10.14.11 | 09:10 am
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 10.10.11 | 09:10 am
- Morning Market Losers - Benzinga 06.06.11 | 09:06 am
- 7 Big Movers That Investors Must Watch This Week - Seeking Alpha 06.06.11 | 08:06 am
- 7 Dirt-Cheap Takeover Targets in Biotech - Seeking Alpha 06.03.11 | 09:06 am
- Orphan Status for Catalyst Drug - Analyst Blog - Zacks 09.22.10 | 06:09 pm
- Biotech's Slow Week Gets Stirred by a Few Smaller Deals - Seeking Alpha 08.15.10 | 04:08 am
